< Back to situations

[ORGANIZATION]

tirzepatide

Featured in 5 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [BR] [FR] [PY]

Brazil ANVISA expands product safety enforcement

21 clusters · 170 sources · last updated

Latest: Brazil's Anvisa suspends multiple medical and consumer products over safety concerns

Since May 2026 Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics and other consumer goods. Early actions suspended batches of statins, dexa

[ACTIVE] [HEALTH] [CR] [CO]

Costa Rica illegal peptide drug market

3 clusters · 6 sources · last updated

Latest: Tirzepatide weight‑loss drug faces illegal use warnings in Costa Rica and Colombia

In late July 2026 Costa Rica’s Ministry of Health issued a nationwide alert after detecting a surge in the illegal online sale of injectable peptide drugs used for weight loss and diabetes treatment. The warning listed c

[QUIET] [HEALTH] [AR] [ES] [IT]

GLP‑1 obesity drug progress and cost issues

3 clusters · 7 sources · last updated

Latest: Italy reviews GLP-1 obesity drugs amid cost and access concerns

Early July reports highlighted Eli Lilly's experimental peptide retatrutide, which in trial data showed greater weight loss than existing GLP‑1 medicines such as Ozempic and Wegovy, suggesting a new option for obesity tr

Also covered in